Current studentsExisting staffContact us
 

Establishing a Human Osteocyte-Staphylococcus Epidermidis Infection Model to Reveal Mechanisms of Chronic Bone and Joint Infections

Simple item page
dc.contributor.authorSiverino, C.
dc.contributor.authorSun, Q.
dc.contributor.authorYang, D.
dc.contributor.authorSolomon, B.
dc.contributor.authorMoriarty, F.
dc.contributor.authorAtkins, G.
dc.date.issued2024
dc.description.abstractBone and joint infection (BJI) is often characterized by severe inflammation and progressive bone destruction. Osteocytes are the most numerous and long-lived bone cell type, and therefore represent a potentially important long-term reservoir of bacterial infection. Staphylococcus aureus is known to establish stable intracellular osteocytic infections, however, little is known about the less virulent yet second most prevalent BJI pathogen, S. epidermidis, associated with late-diagnosed, chronic BJI. Thus, this study sought to establish an in vitro model to study the infection characteristics of S. epidermidis in human osteocyte-like cells. Methods SaOS2 cells (1 ×104 cells/cm2) were grown to confluence either without differentiation, representing an osteoblast-like (OB) state (SaOS2-OB) or differentiated to an osteocyte-like stage (SaOS2-OY), using established methods. Four S. epidermidis strains used (ATCC-12228, ATCC-14990, ATCC-35984 and a clinical osteomyelitis strain RAH-SE1) were tested to be Lysostaphin-resistant, necessitating antibiotic (Levofloxacin) control of extracellular bacteria. Infection of host cells (OB or OY) was tested at three multiplicities of infection (MOI: 10, 100 and 1000). Extracellular bacteria were controlled by overnight incubation at a 10X minimum inhibitory concentration (MIC) of Levofloxacin and thereafter at 1XMIC. At each time point (days 1, 3, 5) viable intra- and extracellular bacteria were quantified. Result All strains displayed similar intracellular infection and persistence capabilities in SaOS2-OB and SaOS2-OY. Independent of MOI, intracellular bacteria in SaOS2-OB decreased over time, becoming non-culturable by day 5. In contrast, SaOs2-OY displayed enhanced intracellular bacterial persistence at each time point. In the presence of increased Levofloxacin concentration (10XMIC), S. epidermidis could persist intracellularly for at least 14 days. Conclusion This study showed for the first time that S. epidermidis can infect human osteocytes and persist intracellularly. Additionally, even a 10xMIC antibiotic concentration failed to eradicate intracellular bacteria, suggesting that persistence within osteocytes could contribute to treatment failure and establishment of chronic BJI.
dc.description.statementofresponsibilitySiverino C, Sun Q, Yang D, Solomon B, Moriarty F, Atkins G.
dc.identifier.citationThe Bone & Joint Journal, 2024; 106-B(S18):40-40
dc.identifier.doi10.1302/1358-992x.2024.18.040
dc.identifier.issn2049-4394
dc.identifier.issn2049-4394
dc.identifier.orcidSun, Q. [0000-0003-4826-6724]
dc.identifier.urihttps://hdl.handle.net/2440/143978
dc.language.isoen
dc.publisherBritish Editorial Society of Bone and Joint Surgery
dc.rights© The Author(s) 2024
dc.source.urihttp://dx.doi.org/10.1302/1358-992x.2024.18.040
dc.subjectBone and joint infection (BJI)
dc.titleEstablishing a Human Osteocyte-Staphylococcus Epidermidis Infection Model to Reveal Mechanisms of Chronic Bone and Joint Infections
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Research Outputs